Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Differential safety profiles of disease-modifying therapies in MS: Age- and sex-based analysis from a real-world cohort.
Renal Disease in ROSAH Syndrome Masquerading as Lupus Nephritis: A Case Report and Cohort Analysis.
Epidemiology of neuromyelitis optica spectrum disease in Central-West Brazil: Prevalence and associated clinical and demographic features.
Factors associated with delays in multiple sclerosis disease-modifying therapy initiation.
Biomimetic Microfibers for Myelin-Enhancer Screening and Neural Regeneration.
Case Report and Literature Review of Spinal Anesthesia-Related Peroneal Nerve Injury Complicated with Diabetic Foot Peripheral Neuropathy.
Longitudinal changes in serum protein levels are associated with disability progression in multiple sclerosis.
Neurogenic Lower Urinary Tract Dysfunction in Women With Multiple Sclerosis.
Adjunctive Non-Disease-Modifying Therapies in Multiple Sclerosis: Immunometabolic, Neuroprotective and Remyelination-Oriented Approaches.
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis.
Video Head Impulse Testing in Relapsing Remitting Multiple Sclerosis: Evaluation of Canal Gains, Asymmetry, and Corrective Saccades with Cerebellar Lesions.
Combined internal neurolysis and targeted proximal trigeminal root glycerol delivery for refractory multiple sclerosis-related trigeminal neuralgia: a case report.
A Comparative Readability Analysis of Artificial Intelligence-Generated and Evidence-based Medical Content on the Diagnosis and Management of Multiple Sclerosis.
Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study.
Lead (Pb) exposure results in cell type specific changes in the mouse retina and optic nerve.
Incidence and prevalence of small fibre neuropathy in the Netherlands: a multiple system estimation study.
Occurrence of neuronal dysfunction in mice with virus- or toxic-induced lesions in the central nervous system.
Comorbidity of uveitis and multiple sclerosis.
N-acetyl-L-leucine in Neurological Disorders: Mechanisms, Evidence, and Therapeutic Perspectives.
Non-MRI biomarkers should be accepted to guide treatment escalation in MS: NO.
Aggressive phenotype of multiple sclerosis, characterised by atypical initial symptoms and a fulminant clinical progression.
Data-driven hypothesis discovery from disease trajectories in multiple sclerosis.
Investigating Depression and MRI Associations in Middle Eastern Relapsing-Remitting Multiple Sclerosis.
Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.
AI-Powered Gradient Echo Plural Contrast Imaging (AI-GEPCI)-A Comprehensive Neurological Protocol From a Single MRI Scan.

Pages